PATENT CLAIM ANALYSIS

Application Number: 15748622
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "017200"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating dry eye, the pharmaceutical composition including, as an active component, a novel peptide is disclosed, wherein it is confirmed that the peptide has effects on improving tear production and corneal surface smoothness for dry eyes induced by desiccation stress and suppressing detachment of corneal epithelial cells, reduction in conjunctival goblet cells, and generation of inflammatory factors, thereby applying a composition including the peptide as an active component to the pharmaceutical composition for preventing or treating dry eye.

Claim (Index 1):
A method of preventing or treating dry eye in a subject in need thereof, comprising:\n providing a pharmaceutical composition comprising, as an active component, a peptide having an amino acid sequence of SEQ ID NO: 1 or 2; and administering the pharmaceutical composition to the subject, wherein the dry eye is prevented or treated.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.64407
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15552529', '15611025', '15125357', '15775835', '12709895']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7385561059581657
- 35 USC 102 Novelty (BERT): 0.4907413234415099
- Combined Prediction Score: 0.7137746277065001
- Mean Citation Score: 211.035994
- Max Citation Score: 220.9922
- Similarity Product: 162.2723765447497

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test